Response to Stimulations Inducing Circadian Rhythm in Human Induced Pluripotent Stem Cells.

Cells
Hitomi KanekoKazuhito Tomizawa

Abstract

Regenerative medicine and disease modeling are expanding rapidly, through the development of human-induced pluripotent stem cells (hiPSCs). Many exogeneous supplements are often used for the directed differentiation of hiPSCs to specific lineages, such as chemicals and hormones. Some of these are known to synchronize the circadian clock, like forskolin (Frk) and dexamethasone (Dex); however, the response to these stimulations has not been fully elucidated for hiPSCs. In this study, we examined the response of clock genes to synchronizing stimulation, and compared it with fully differentiated cells, U2OS, and fibroblasts. The expression of clock genes did not show circadian rhythms in hiPSCs with Frk and Dex, which could be due to the significantly low levels of BMAL1. On the other hand, a circadian-like rhythm of D-box binding protein (DBP) expression was observed in hiPSCs by culturing them in an environment with a simulated body temperature. However, the inhibition of temperature-inducible factors, which are involved in temperature rhythm-induced synchronization, could not repress the expression of such rhythms, while the inhibition of HIF-1α significantly repressed them. In summary, we suggest that clock genes do not respond...Continue Reading

References

Dec 28, 1999·Annual Review of Cell and Developmental Biology·G L Semenza
Oct 10, 2002·Current Biology : CB·Steven A BrownUeli Schibler
Jun 28, 2003·Journal of Cell Science·Norma Masson, Peter J Ratcliffe
Apr 2, 2005·Nature Reviews. Molecular Cell Biology·Martin Holcik, Nahum Sonenberg
Jun 15, 2005·Annual Review of Biochemistry·William G Kaelin
Sep 20, 2008·Nature Reviews. Genetics·Joseph S TakahashiErin L McDearmon
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Alex Y -L SoBrian J Feldman
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro YagitaYasuo Uchiyama
May 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jacob HannaRudolf Jaenisch
Oct 12, 2010·Journal of Cell Science·Yool LeeKyungjin Kim
Dec 8, 2010·Journal of Biological Rhythms·Elzbieta KowalskaSteven A Brown
Apr 16, 2013·Nature Methods·Sundari ChettyDouglas A Melton
Oct 1, 2013·Cell·Siim Pauklin, Ludovic Vallier
Feb 7, 2014·The EMBO Journal·Haruhisa InoueShinya Yamanaka
Jun 26, 2015·Stem Cells·Galbha DuggalBjörn Heindryckx
Dec 19, 2016·Nature Reviews. Genetics·Joseph S Takahashi
May 26, 2017·EMBO Reports·Pieterjan DierickxLinda W Van Laake
Aug 23, 2017·Proceedings of the National Academy of Sciences of the United States of America·Yasuhiro UmemuraKazuhiro Yagita
Oct 18, 2018·Physiological Reviews·Peter KaragiannisKenji Osafune
Aug 2, 2019·Journal of Biological Rhythms·Yasuhiro UmemuraKazuhiro Yagita

❮ Previous
Next ❯

Citations

Feb 2, 2021·Frontiers in Physiology·Joyce BernardiAdemuyiwa S Aromolaran

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Flow Cytometry
chip
nuclear translocation
ubiquitination

Software Mentioned

Synergy
KaleidaGraph
FACSuite
ImageJ

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.